Skip to main content
Cancer Biology & Medicine logoLink to Cancer Biology & Medicine
. 2019 Nov;16(4):836. doi: 10.20892/j.issn.2095-3941.2019.0401

Erratum to Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer

Yuxiang Wang 1,2, Xian Li 1, Xueling Liu 1,2, Yi Chen 2,3, Chunhao Yang 4, Cun Tan 4, Bobo Wang 1, Yiming Sun 2,3, Xi Zhang 1, Yinglei Gao 2,3, Jian Ding 2,3,*, Linghua Meng 1,2,*
PMCID: PMC6936228  PMID: 31908900

In the published Figure 11, errors appeared in Figure 1B on page 69. In Figure 1B, bands for p-Akt S473, Akt, and Actin in H1355 cells were mistakenly placed. Here, we have updated Figure 1B to correct the mistake above. The errors do not impact the conclusions of this article. We apologize for the errors and for any confusion it may have caused.

1B.

1B

NSCLC cells were treated with CYH33 at theindicated concentrations for 1 h. Cell lysates were subjected to Western blot with the indicated antibodies.

Contributor Information

Jian Ding, Email: jding@simm.ac.cn.

Linghua Meng, Email: lhmeng@simm.ac.cn.

References

  • 1.Wang YX, Li X, Liu XL, Chen Y, Yang CH, Tan C, et al Simultaneous inhibition of pi3k alpha and cdk4/6 synergistically suppresses kras-mutated non-small cell lung cancer. Cancer Biol Med. 2019;16:66–83. doi: 10.20892/j.issn.2095-3941.2018.0361. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancer Biology & Medicine are provided here courtesy of Chinese Anti-Cancer Association

RESOURCES